secwatch / observer
8-K filed November 30, 2023, 6:59 PM ET ticker GCTK CIK 0001506983
regulatory confidence high sentiment negative materiality 0.65

Glucotrack, Inc. (GCTK): Nasdaq/NYSE listing notice — Glucotrack gets 180-day Nasdaq extension to May 20, 2024 to regain $1.00 bid price compliance

Glucotrack, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Glucotrack, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
extension granted
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
November 24, 2023, the Company received a letter from Nasdaq notifying the Company that it has been granted an additional 180 calendar days, or until May 20, 2024 (the “Extended Compliance Period”), to regain compliance with the Minimum Bid Price Requirement in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If at any time during the Extended Compliance Period, the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Staff will provide written confirmation that the Company has achieved compliance with the Minimum Bid
View on SEC.gov

Browse all listing & compliance notices →

Glucotrack, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-043264
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.